Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 6.48M | $721.0M | 9.32% | -630.5K | 2026-03-31 |
| UBS Group AG | 4.55M | $506.0M | 6.54% | +123.5K | 2026-03-31 |
| Darwin Global Management, Ltd. | 3.47M | $352.0M | 4.99% | +290.2K | 2026-03-31 |
| MORGAN STANLEY | 1.70M | $189.0M | 2.45% | -1.45M | 2026-03-31 |
| Vestal Point Capital, LP | 1.50M | $167.0M | 2.16% | -400.0K | 2026-03-31 |
| Caligan Partners LP | 1.46M | $162.0M | 2.10% | +10.0K | 2026-03-31 |
| ADAR1 Capital Management, LLC | 1.44M | $160.0M | 2.07% | +120.7K | 2026-03-31 |
| CITADEL ADVISORS LLC | 1.34M | $149.0M | 1.93% | +255.5K | 2026-03-31 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.32M | $147.0M | 1.90% | +313.0K | 2026-03-31 |
| FMR LLC | 1.29M | $143.0M | 1.85% | -79.3K | 2026-03-31 |
